What changed
FACT (cited Federal Register doc 2026-13047, published 2026-06-29): FDA proposed a rule prescribing the format, content, and procedures for tobacco establishment registration and product listing, and the preamble notes that currently only domestic owners/operators are covered — the proposal is the vehicle for extending prescribed registration/listing obligations to foreign establishments. HYPOTHESIS: thousands of foreign (largely Shenzhen vape/e-liquid) establishments will need to file in a prescribed format for the first time, and US importers will need a way to confirm supplier status to protect entry of goods.
Why now
The rule is at the proposed stage — the pre-finalization window where the filing format is still being set. Building the dossier template and verification layer against the proposed format, and participating in the comment docket, positions the product as the de facto tooling at finalization. INFERENCE: no third-party template or importer-side verification product exists yet for this specific rule because the format was only published June 2026.
Converging signals
(1) FACT: FDA proposed rule 2026-13047 prescribing tobacco establishment registration/product listing format and content, with foreign coverage as the stated gap. (2) System lesson (confidence 0.80): government-portal mandate opportunities are this founder's highest-fit shape. (3) INFERENCE from the Reverse-KYC Passport pattern: the foreign filer is hard to bill, but the US importer/broker is a domestically invoiceable chokepoint whose line release depends on supplier compliance. Note: only one underlying demand signal (the rule itself, listed twice under FDA and HHS) — this is a thin convergence, and I score convergence accordingly.
Customer pain
HYPOTHESIS (no PAIN-type evidence in input): foreign manufacturers cannot easily self-file into a US portal in a prescribed format (language, US agent, FURLS/TRLM-style account friction), and importers/brokers have no reliable way to verify a supplier's registration status before accepting goods whose entry could be refused. The testable prediction in the input (5 of 25 importers/brokers confirm no verification method and willingness to pay) is the right validation gate and has not yet been run.
Who pays
Two parties: (A) foreign tobacco/vape/e-liquid manufacturers pay an annual fee for a maintained 'passport' dossier (creation, prescribed-format filing, renewal, change-of-information updates); (B) US importers, distributors, and customs brokers pay per-shipment or per-supplier-review to verify registration status. Party B is the reachable, domestically invoiceable buyer; party A is higher-volume but harder to bill (payment rails from China are solvable but add friction — HYPOTHESIS).
Solved today
HYPOTHESIS: today foreign establishments are not required to register at all (the rule's stated gap), so nothing is 'solved.' The adjacent problem — FDA registration agency for food/drug/device facilities and tobacco PMTA support — is served by established registration agents (Registrar Corp, FDAImports) and regulatory law firms (Keller and Heckman). These incumbents are the natural fast-followers.
Why current solutions are bad
There is no current solution because the obligation does not yet exist for foreign establishments. The gap is anticipatory: when the rule finalizes with a compliance deadline, a large cohort must file at once in a prescribed format, and importers must suddenly care about supplier status. Incumbents serve food/drug registration but (INFERENCE) have not built tobacco-specific tooling against a format published only weeks ago.
Proposed product
Two-sided micro-SaaS: (1) 'FDA Tobacco Passport' — intake wizard that produces a complete, prescribed-format registration + product-listing dossier per foreign establishment, files/updates it when the portal opens, tracks renewal windows, and issues a shareable status certificate; (2) verification portal/API where importers and brokers look up or continuously monitor supplier registration status per shipment. The certificate becomes a demanded artifact in purchase orders, enforcing adoption supplier-by-supplier.
MVP version
Before finalization: a static dossier-builder mapped to the proposed rule's data elements, plus a 'readiness report' PDF per establishment and a waitlist-backed importer lookup stub. This is buildable solo in 3-6 weeks with AI-assisted development; no portal integration exists to build against yet, which keeps MVP scope honest and cheap.
30-day build
Read the full proposed rule and map every required data element into an intake schema. Pull the regulations.gov docket for 2026-13047 comments to identify importers/brokers/trade groups citing verification or filing burden (this is also the evidence-needed test). Run the 25-contact outreach test to importers and customs brokers. File a comment positioning as a service provider (also marketing).
60-day build
Launch the readiness-report product for foreign manufacturers via the channels that already sell them PMTA services (vape trade media, sourcing agents, Alibaba-adjacent consultants — HYPOTHESIS on channel efficacy). Sign 2-3 customs brokers as design partners for the verification API. Build the passport certificate format.
90-day revenue plan
Realistic first revenue: paid readiness reports/pre-registration retainers from foreign manufacturers ($500-$1,500 each) and paid pilot commitments from brokers. Material recurring revenue (per-shipment verification) only arrives at/after rule finalization and effective date — likely OUTSIDE 180 days. This is the central timing risk: revenue inside 180 days is preparation-services revenue, not the core wedge.
Distribution path
Customs brokers are a concentrated, listable, reachable channel (a few thousand licensed US brokers; the vape-importing subset is smaller and identifiable from import records). Foreign manufacturers reachable through the existing PMTA-consulting ecosystem and trade shows. Demonstrated-value sales fit: a free supplier-status lookup teaser that upsells monitoring matches the founder's no-relationship-sales style.
Pricing hypothesis
Passport: $995/yr per establishment (creation + maintenance + updates), $295 per additional product listing batch. Verification: $49/mo per importer for monitoring up to 10 suppliers, or $15 per one-off verification report. All HYPOTHESIS — anchor against what these firms pay PMTA consultants (orders of magnitude more) suggests headroom.
Technical difficulty
Low-to-moderate. Dossier builder, doc generation, and a lookup portal are standard solo-buildable web work. The eventual FDA portal submission layer is unknown until the final rule specifies mechanism (FURLS/TRLM-style web portal likely; may lack an API, forcing operator-in-the-loop filing — which the founder has already proven he can do profitably with FMCSA ELDT).
Legal / regulatory risk
Moderate but manageable. Acting as a registration agent/US agent for FDA-regulated establishments is an established, unlicensed service category. Tobacco/vape adds payment-processor squeamishness and reputational load, not legal prohibition (the service is compliance, not product sale). Key risk is misrepresentation liability if a 'verified' supplier turns out non-compliant — mitigate with clear scope-of-verification language.
Platform dependency
High on FDA. Two specific dependencies: (1) the rule must finalize in a form resembling the proposal; (2) KILL CONDITION from the input, unresolved: if FDA exposes a free, real-time public lookup of establishment registration status, the importer-side verification product collapses to a thin wrapper (precedent is mixed: drug establishment data is public, food facility registration is confidential — INFERENCE that tobacco's treatment is genuinely uncertain). The manufacturer-side passport/filing service survives a free lookup; the verification portal may not.
Founder fit
Very high on shape: this is exactly the proven ELDT pattern — a federal mandate compels a class of filers, a solo operator builds the submission layer and charges per filing. The high-confidence system lesson (0.80) on government-portal mandates applies directly. Deductions: foreign-party billing is new to him, and tobacco is a category he has no domain background in (unlike trucking-adjacent ops).
Breakout potential
The Reverse-KYC Passport pattern replicates across other FDA programs (food FSVP verification, drug establishment) and other agencies whenever a rule extends filing duties to foreign parties — the intake/verification chassis is reusable. Realistic ceiling as a solo business: high-margin niche compliance SaaS in the low seven figures ARR, not venture-scale.
Final recommendation
CONDITIONAL GO — cheap validation now, no heavy build yet. The shape is the founder's proven best (forced-buyer government filing, per-transaction monetization) and the pre-finalization window is real, but the two kill conditions are live and testable for near-zero cost: (1) run the 25-contact importer/broker outreach test, (2) mine the regulations.gov docket for verification-burden comments and check whether FDA signals a public status database. Spend 2-4 weeks and <$1k on validation before committing the 3-6 week MVP build. If both tests pass, this is a top-decile fit; if the free-lookup risk confirms, pivot to manufacturer-side filing-only.
Next action
Pull the full text of Federal Register doc 2026-13047 and its regulations.gov docket: extract the exact required data elements, the proposed submission mechanism, comment-period deadline, and any mention of public disclosure of registration status; simultaneously build the list of 25 US vape/tobacco importers and customs brokers for the outreach test.